Effective health care: Management of head and neck cancers

Quality and Safety in Health Care

Volumn 14, Issue 2, 2005, Pages 144-148

  Collins, R ^a   Flynn, A ^b   Melville, A ^c   Richardson, R ^a   Eastwood, A ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; EARLY DIAGNOSIS; HEAD AND NECK CANCER; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; OUTCOMES RESEARCH; PATIENT CARE; QUALITY CONTROL; RESEARCH; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING;

EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HEAD AND NECK NEOPLASMS; HUMANS; PATIENT CARE MANAGEMENT; PRACTICE GUIDELINES; STATE MEDICINE;

EID: 17144426455     PISSN: 14753898     EISSN: None     Source Type: Journal    
DOI: 10.1136/qshc.2005.013961     Document Type: Review

References (92)

1. Centre for Reviews and Dissemination. Management of head and neck cancers. Effective Health Care 2004;8:5.
2. National Institute for Clinical Excellence (NICE). Guidance on cancer services: improving outcomes in head and neck cancers: the manual. London: NICE, 2004.
3. Centre for Reviews and Dissemination. Guidance on cancer services: improving outcomes in head and neck cancers: the research evidence. York: Centre for Reviews and Dissemination, 2004.
4. Office of National Statistics. Data provided on request by the Office of National Statistics (ONS). London: ONS, 2002.
5. Welsh Cancer Intelligence & Surveillance Unit. Data provided on request by the Welsh Cancer Intelligence & Surveillance Unit, 2002.
6. South West Cancer Intelligence Service (SWICS). Second head and neck audit report. Bristol: SWICS, 2001.
7. Kowalski LP, Franco EL, Torloni H, et al. Lateness of diagnosis of oral and oropharyngeal carcinoma: factors related to the tumour, the patient and health professionals. Eur J Cancer B Oral Oncol 1994;3:167-73.
8. Robertson AG, Robertson C, Soutar DS, et al. Treatment of oral cancer: the need for defined protocols and specialist centres. Variations in the treatment of oral cancer. Clin Oncol 2001;13:409-15.
9. Field EA, Morrison T, Darling AE, et al. Oral mucosal screening as an integral part of routine dental care. Br Dent J 1995;179:262-6.
10. Hoare TJ, Thomson HG, Proops DW. Defection of laryngeal cancer: the case for early specialist assessment. J R Soc Med 1993;86:390-2.
11. Resouly A, Hope A, Thomas S. A rapid access husky voice clinic: useful in diagnosing laryngeal pathology. J Laryngol Otol 2001;115:978-80.
12. McCombe A, George E. One-stop neck lump clinic. Clin Otolaryngol 2002:27.
13. Murray A, Stewart CJ, McGarry GW, et al. Patients with neck lumps: can they be managed in a One-stop' clinic setting? Clin Otolaryngol 2000;25:471-5.
14. Kishore A, Stewart CJ, McGarry GW, et al. One-stop neck lump clinic: phase 2 of audit. How are we doing? Clin Otolaryngol 2001;26:495-7.
15. Vowles RH, Ghiacy S, Jefferis AF. A clinic for the rapid processing of patients with neck masses. J Laryngol Otol 1998;112:1061-4.
16. Edwards D. Face to face. London: King's Fund, 1997.
17. Edwards D. Head and neck cancer services: views of patients, their families and professionals. Br J Oral Maxillofac Surg 1998;36:99-102.
18. Anton JV, Gstöttner W, Matula C. Interdisciplinary surgical treatment of anterior skull base tumors. Wien Klin Wochenschr 1999;111:560-7.
19. Lehmann W, Krebs H. Interdisciplinary rehabilitation of the laryngectomee. Recent Results Cancer Res 1991;121:442-9.
20. Johnson JT, Casper J, Lesswing NJ. Toward the total rehabilitation of the alaryngeal patient. Laryngoscope 1979;89:1813-9.
21. Minear D, Lucente FE. Current attitudes of laryngectomy patients. Laryngoscope 1979;89:1061-5.
22. Flynn MB, Leightty FF. Preoperative outpatient nutritional support of patients with squamous cancer of the upper aerodigestive tract. Am J Surg 1987;154:359-62.
23. Piquet MA, Ozsahin M, Larpin I, et al. Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy. Support Care Cancer 2002;10:502-4.
24. Seikaly H, Calhoun KH, Stonestreet JS, et al. The impact of a skilled nursing facility on the cost of surgical treatment of major head and neck tumors. Arch Otolaryngol Head Neck Surg 2001;127:1086-8.
25. Sosa JA, Bowman HM, Tielsch JM, et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998;228:320-30.
26. Pisani T, Bononi M, Nagar C, et al. Fine needle aspiration and core needle biopsy techniques in the diagnosis of nodular thyroid pathologies. Anticancer Res 2000;20:3843-7.
27. Warner GC, Cox GJ. Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer. Am J Otolaryngol 2003;32:107-9.
28. Arunachalam PS, Putnam G, Jennings P, et al. Role of computerized tomography (CT) scan of the chest in patients with newly diagnosed head and neck cancers. Clin Otolaryngol 2002;27:409-11.
29. Lees J. Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: a two year study. Eur J Cancer Care 1997;6:45-9.
30. Lizi EC. A case for a dental surgeon at regional radiotherapy centres. Br Dent J 1992;173:24-6.
31. Epstein JB, Emerton S, Lunn R, et al. Pretreatment assessment and dental management of patients with nasopharyngeal carcinoma. Oral Oncol 1999;35:33-9.
32. Brown RS, Miller JH, Bottomley WK. A retrospective oral/dental evaluation of 92 head and neck oncology patients, before, during and after irradiation therapy. Gerodontology 1990;9:35-9.
33. Lockhart PB, Clark J. Pretherapy dental status of patients with malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 1994;77:236-41.
34. Horiot JC, Bone MC, Ibrahim E, et al. Systematic dental management in head and neck irradiation. Int J Radiat Oncol Biol Phys 1981;7:1025-9.
35. Chan Y, Irish JC, Wood SJ, et al. Patient education and informed consent in head and neck surgery. Arch Otolaryngol Head Neck Surg 2002;128:1269-74.
36. Feber T. Design and evaluation of a strategy to provide support and information for people with cancer of the larynx. Eur J Oncol Nurs 1998;2:106-14.
37. Clarke A. Resourcing and training head and neck cancer nurse specialists to deliver a social rehabilitation programme to patients. D Clin Psychol, City University, 2001.
38. Semple C, Allam C. Providing written information for patients with head and neck cancer. Prof Nurse 2002;17:620-2.
39. Browman GP, Hodson DI, Mackenzie RG, et al. Concomitant chemotherapy and radiotherapy in squamous cell head and neck cancer (excluding nasopharynx). Practice guideline 5-6a. Cancer Care Ontario Practice Guideline Initiative, 2000. Available at http://www.cancercare.on.ca/pdf/full5_6a.pdf.
40. Browman GP, Hodson DI, Mackenzie RJ, et al. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579-89.
41. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83-91.
42. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949-55.
43. Browman GP, Charette M, Oliver T, et al. Neoadjuvant chemotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN) (excluding nasopharynx). Practice Guideline 5-1. Cancer Care Ontario Practice Guideline Initiative, 2003. Available at http://www.cancercare.on.ca/pdf/sumry5_1.pdf.
44. Henk JM. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol 1997;9:308-12.
45. Thephamongkhol K, Browman GP, Hodson DI, et al. The role of chemotherapy with radiotherapy in the management of patients with newly diagnosed locally advanced squamous cell or undifferentiated nasopharyngeal cancer. Practice Guideline 5-7, Cancer Care Ontario Practice Guideline Initiative, 2003. Available at http://www.cancercare.on.ca/pdf/pebc5-7f.pdf.
46. Mackenzie RG. Accelerated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Practice Guideline 5-6c. Cancer Care Ontario Practice Guideline Initiative, 2003. Available at http://www.cancercare.on.ca/ pdf/sumry5_6c.pdf.
47. Mackenzie RG, Hodson DI, Head and Neck Cancer Diseases Site Group. Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Practice Guideline 5-6b. Cancer Care Ontario Practice Guideline Initiative, 2003. Available at http://www.cancercare.on.ca/pdf/ sumry5_6b.pdf.
48. Stuschke M, Thames HD. Hyperfractionated radiotherapy of human tumors - overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 1997;37:259-67.
49. Robertson AG, Robertson C, Perone C, et al. Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis. Radiother Oncol 1998;48:165-73.
50. Robertson G, Parmar M, Foy C, et al. Overall treatment time and the conventional arm of the CHART trial in the radiotherapy of head and neck cancer. Radiother Oncol 1999;50:25-8.
51. Robertson C, Robertson AG, Hendry JH, et al. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 1998;40:319-29.
52. Kwong DL, Sham JS, Chua DT, et al. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1997;39:703-10.
53. Khalil AA, Bentzen SM, Bernier J, et al. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Int J Radiat Oncol Biol Phys 2003;55:568-75.
54. Roberts SA, Hendry JH, Brewster AE, et al. The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor. Br J Radiol 1994;67:790-4.
55. Huang J, Barbera L, Brouwers M, et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003;21:555-63.
56. Sutherland SE, Browman GP. Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: A proposed classification scheme of interventions and meta-analysis of randomized controlled trial. Int J Radiat Oncol Biol Phys 2001;49:917-30.
57. Hodson DI, Browman GP, Thephamongkhol K, et al. The role of amifostine as a radioprotectant in the management of patients with squamous cell head and neck cancer. Practice Guideline 5-8. Cancer Care Ontario Practice Guideline Initiative, 2003. Available at http://www.cancercare.on.ca/pdf/pebc5-8f.pdf.
58. Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment (Cochrane Review). The Cochrane Library. Issue 2. Chichester, UK: John Wiley & Sons Ltd, 2003.
59. Hawthorne M, Sullivan K. Pilocarpine for radiation-induced xerostomia in head and neck cancer. Int J Palliat Nurs 2000;6:228, 30-2.
60. Hodson DI, Haines T, Berry M, et al. Symptomatic treatment of radiation-induced xerostomia in head and neck cancer patients. Practice guideline 5-5. Cancer Care Ontario Practice Guideline Initiative; 2002. Available at http://www.cancercare.on.ca/pdf/full5_5.pdf.
61. Smid L, Lesnicar H, Zakotnik B, et al. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer - preliminary report. Int J Radiat Oncol Biol Phys 1995;32:769-75.
62. de Maddalena H, Pfrang H. Improvement of communication behavior of laryngectomized and voice-rehabilitated patients by a psychological training program. HNO 1993;41:289-95.
63. Sittel C, Eckel HE, Eschenburg C. Phonatory results after laser surgery for glottic carcinoma. Otolaryngol Head Neck Surg 1998;119:418-24.
64. Sittel C, Eckel HE, Eschenburg C, et al. Voice quality after partial laser laryngectomy. Laryngorhinootologie 1998;77:219-25.
65. Bachher GK, Dholam K, Pai PS. Effective rehabilitation after partial glossectomy. Indian J Otolaryngol 2002;54:39-43.
66. Hocevar-Boltezar I, Smid L, Zargi M, et al. Factors influencing rehabilitation in patients with head and neck cancer. Radiother Oncol 2000;34:289-94.
67. Dejonckere PH. Functional swallowing therapy after treatment for head and neck cancer can outcome be predicted? Rev Laryngol Otol Rhinol (Bord) 1998;119:239-43.
68. Perry AR, Shaw MA, Evaluation of functional outcomes (speech, swallowing and voice) in patients attending speech pathology after head and neck cancer treatment(s): development of a multi-centre database. J Laryngol Otol 2000;114:605-15.
69. Meyerson MD, Johnson BH, Weitzman RS. Rehabilitation of a patient with complete mandibulectomy and partial glossectomy. Am J Otolaryngol 1980;1:256-61.
70. Logemann JA, Pauloski BR, Rademaker AW, et al. Speech and swallowing rehabilitation for head and neck cancer patients. Oncology 1997;11:651-64.
71. Gates GA, Ryan W, Cooper JC, et al. Current status of laryngectomee rehabilitation: I. Results of therapy. Am J Otolaryngol 1982;3:1-7.
72. Smithwick L, Davis P, Dancer J, et al. Female laryngectomees' satisfaction with communication methods and speech-language pathology services. Percept Mot Skills 2002;94:204-6.
73. Weischer T, Mohr C. Ten-year experience in oral implant rehabilitation of cancer patients: treatment concept and proposed criteria for success. Int J Oral Maxillofac Implants 1999;14:521-8.
74. Gransfrom G, Tjellstrom A, Branemark PI. Osseointegrated implants in irradiated bone: a case-controlled study using adjunctive hyperbaric oxygen therapy. J Oral Maxillofac Surg 1999;57:493-9.
75. Goto M, Jin-Nouchi S, Ihara K, et al. Longitudinal follow-up of osseointegrated implants in patients with resected jaws. Int J Oral Maxillofac Implants 2002;17:225-30.
76. Esser E, Wagner W. Dental implants following radical oral cancer surgery and adjuvant radiotherapy. Int J Oral Maxillofac Implants 1997;12:552-7.
77. Wagner W, Esser E, Ostkamp K. Osseointegration of dental implants in patients with and without radiotherapy. Acta Oncol 1998;37:693-6.
78. Granstrom G, Tjellstrom A, Branemark PI, et al. Bone-anchored reconstruction of the irradiated head and neck cancer patient. Otolaryngol Head Neck Surg 1993;108:334-43.
79. Kovacs AF. The fate of osseointegrated implants in patients following oral cancer surgery and mandibular reconstruction. Head Neck 2000;22:111-9.
80. Kovacs AF. Assessment of prosthetic restorations on bone-lock implants in patients after oral tumor resection. Int J Oral Implantol 1998;24:101-9.
81. Kovacs AF. Influence of chemotherapy on endosteal implant survival and success in oral cancer patients. Int J Oral Maxillofac Surg 2001;30:144-7.
82. Birkhaug EJ, Aarstad HJ, Aarstad AK, et al. Relation between mood, social support and the quality of life in patients with laryngectomies. Eur Arch Otorhinolaryngol 2002;259:197-204.
83. Mathieson CM, Logan-Smith LL, Phillips J, et al. Caring for head and neck oncology patients. Does social support lead to better quality of life? Can Fam Physician 1996;42:1712-20.
84. Harris LL, Vogtsberger KN, Mattox DE. Group psychotherapy for head and neck cancer patients. Laryngoscope 1985;95:585-7.
85. Hell B. First experience with a self-help group of cancer patients of the oral and maxillofacial surgery department. Disch Z Mund Kiefer Gesichtschir 1987;11:234-5.
86. Hammerlid E, Persson LO, Sullivan M, et al. Quality-of-life effects of psychosocial intervention in patients with head and neck cancer. Otolaryngol Head Neck Surg 1999;120:507-16.
87. Virgo KS, Paniello RC, Johnson FE. Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg 1998;124:564-72.
88. Chong VF, Fan YF. Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 1997;202:463-70.
89. Lapela M, Eigtved A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000;30:858-67.
90. Bongers V, Hobbelink MG, van Rijk PP, et al. Cost-effectiveness of dual-head F-18-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer. Cancer Biother Radiopharm 2002;17:303-6.
91. Di Martina E, Hausmann R, Krombach GA, et al. Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer. Laryngorhinootologie 2002;81:866-74.
92. Goerres GW, Haenggeli CA, Allaoua M, et al. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck. Nuklearmedizin 2000;39:246-50.